Marble Harbor Investment Counsel LLC Acquires 46,525 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Marble Harbor Investment Counsel LLC boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 10.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 495,073 shares of the pharmacy operator’s stock after acquiring an additional 46,525 shares during the quarter. Marble Harbor Investment Counsel LLC owned 0.06% of Walgreens Boots Alliance worth $5,988,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in WBA. Quadrant Capital Group LLC lifted its holdings in shares of Walgreens Boots Alliance by 33.8% during the fourth quarter. Quadrant Capital Group LLC now owns 7,494 shares of the pharmacy operator’s stock valued at $196,000 after acquiring an additional 1,893 shares during the period. Syon Capital LLC bought a new position in Walgreens Boots Alliance during the 4th quarter valued at about $333,000. EP Wealth Advisors LLC acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at about $297,000. Corient Private Wealth LLC grew its stake in Walgreens Boots Alliance by 38.9% during the fourth quarter. Corient Private Wealth LLC now owns 280,545 shares of the pharmacy operator’s stock worth $7,325,000 after buying an additional 78,523 shares during the last quarter. Finally, Sanders Morris Harris LLC increased its holdings in shares of Walgreens Boots Alliance by 373.3% during the first quarter. Sanders Morris Harris LLC now owns 112,398 shares of the pharmacy operator’s stock worth $2,438,000 after buying an additional 88,650 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $9.21 on Monday. The stock has a market cap of $7.95 billion, a PE ratio of -1.37, a price-to-earnings-growth ratio of 0.98 and a beta of 0.70. The stock has a 50-day moving average of $10.51 and a 200-day moving average of $15.10. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. Walgreens Boots Alliance, Inc. has a one year low of $8.46 and a one year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The firm had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same period in the prior year, the business earned $1.00 earnings per share. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.86%. The ex-dividend date was Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Analyst Ratings Changes

Several research analysts have recently commented on WBA shares. Truist Financial reduced their target price on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a report on Friday, June 28th. JPMorgan Chase & Co. decreased their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. Bank of America cut their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Thursday. Finally, Royal Bank of Canada dropped their target price on shares of Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating for the company in a research note on Tuesday, July 2nd. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $14.73.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.